An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Popularity Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Experts Express Worries
However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.
Some experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.
Platform Response and Content Elimination
Based on TikTok, the service has taken down violative material and banned associated keywords and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.
Product Details and Pricing
Within these communities, posts display dark colored packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly significant medical dangers”.
